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Abstract Brain functions, including cognitive functions,
are frequently disturbed in brain tumor patients. These
disturbances may result from the tumor itself, but also from
the treatment directed against the tumor. Surgery, radio-
therapy and chemotherapy all may affect cerebral func-
tioning, both in a positive as well as in a negative way.
Apart from the anti-tumor treatment, glioma patients often
receive glucocorticoids and anti-epileptic drugs, which
both also have influence on brain functioning. The effect of
a brain tumor on cerebral functioning is often more global
than should be expected on the basis of the local character
of the disease, and this is thought to be a consequence of
disturbance of the cerebral network as a whole. Any
network, whether it be a neural, a social or an electronic
network, can be described in parameters assessing the
topological characteristics of that particular network.
Repeated assessment of neural network characteristics in
brain tumor patients during their disease course enables
study of the dynamics of neural networks and provides
more insight into the plasticity of the diseased brain.
Functional MRI, electroencephalography and especially
magnetoencephalography are used to measure brain func-
tion and the signals that are being registered with these
techniques can be analyzed with respect to network char-
acteristics such as ‘‘synchronization’’ and ‘‘clustering’’.
Evidence accumulates that loss of optimal neural network
architecture negatively impacts complex cerebral func-
tioning and also decreases the threshold to develop
epileptic seizures. Future research should be focused on
both plasticity of neural networks and the factors that have
impact on that plasticity as well as the possible role of
assessment of neural network characteristics in the deter-
mination of cerebral function during the disease course.
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Introduction
Optimal functioning of the brain depends on a large
number of factors. Motor and sensory functioning, cogni-
tive functioning, autonomic functioning, as well as emo-
tional and social functioning all depend on anatomic and
physiological integrity of the neural networks.
This integrity may be disturbed by numerous factors,
varying from intrinsic brain disease to mood disorders and
from metabolic disturbances and general disease to exog-
enous intoxications. Intrinsic brain disease may be focal,
multifocal or generalized, and examples from these cate-
gories are brain tumors, multiple sclerosis and encephalitis,
respectively. But optimal functioning of the brain is also
determined by an intact environment. Cerebral functioning
in a person who is generally ill as a result of infectious
disease or disseminated cancer may be severely impaired.
Consciousness and cognition may be hampered by a dis-
turbed liver function, by hypoglycemia or by acidosis. And
exogenous intoxications by carbon monoxide or alcohol,
but also by numerous sorts of medication, such as sedative
drugs, antidepressants and anti-epileptic drugs, may have a
strong impact on functioning of the brain.
In patients with brain tumors, disorders of cerebral
functioning are a major concern and it is important to
realize that not only the tumor itself but also our broad
array of therapeutic interventions and all kinds of
J. J. Heimans (&)  J. C. Reijneveld
Department of Neurology, VU University Medical Center,
De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
e-mail: j.heimans@vumc.nl
123
J Neurooncol (2012) 108:231–237
DOI 10.1007/s11060-012-0814-7
metabolic, psychological and social factors contribute to
the cerebral condition that determines how the patient is
able to express his emotions, how he is able to think, how
he functions in his work and in his social environment, and,
finally, what his quality of life is.
Brain tumors and cerebral function: general
considerations
Brain tumors almost invariably cause severe symptoms,
such as focal neurological deficits, cognitive deficits, and
focal or generalized epileptic seizures. Apart from that,
brain tumors may give rise to increased intracranial pres-
sure, resulting in headache or impairment of consciousness.
Brain tumors have this significant impact on the brain,
since they force the non-tumoral brain tissue not only to
adapt to the presence of an expanding mass, but also to the
invasion of healthy brain tissue by infiltrating tumor cells.
How this adaptive process takes place has yet to be elu-
cidated. It is a great challenge to clarify the underlying
mechanisms accounting for the changes in the brain’s
functional status resulting from the presence of this foreign
entity and leading to cognitive impairments, to an alter-
ation of emotional functioning, and to epileptic seizures.
When reviewing the current knowledge in neuro-oncology,
there is a strong need for theory regarding the complex
relations between the tumor on the one hand, and epilepsy
and cognitive and emotional status on the other hand. The
study of these relations is complicated by the fact that
patients with primary brain tumors undergo a large number
of therapeutic interventions, starting with surgery, which is
almost invariably followed by irradiation, and in a number
of cases by chemotherapy. Apart from these anti-tumor
treatment modalities, brain tumor patients may receive
antiepileptic drugs, antidepressants and corticosteroids, all
having their specific impact on cerebral functioning.
Brain tumors, cognition and epilepsy
Cognitive functioning may be impaired in many conditions
that affect the brain. But ‘‘cognitive functioning’’ as such is
an ill-defined entity. Cognition is a collective term for a
number of functions that can be subdivided into different
domains. The six most important domains are (1) infor-
mation processing, (2) psychomotor functioning, (3)
attention, (4) verbal memory, (5) working memory, and (6)
executive functioning [1]. In order to get properly informed
on the cognitive abilities of an individual patient, a number
of cognitive tests should be performed, measuring these
separate functions. The more extensive the test battery, the
more detailed the information on the cerebral functioning
of the patient.
A number of studies on cognitive functioning in glioma
patients have been published. Most brain tumor patients
experience cognitive deficits at some point during their
disease. Severe neuropsychological impairments have been
found in up to 89% of patients with high-grade gliomas
(HGG) [2–4]. A comparable percentage of patients with
low-grade gliomas (LGG) display cognitive deficits [5–12].
The most striking collective finding of these studies is that
cognitive deficits are not restricted to the area of the brain
where the tumor is located and where it has caused local
damage, but rather should be traced to a more global
dysfunctioning of the brain: memory disturbances, loss of
concentration, difficulties with planning and language, and
psychomotor slowness.
It appears that the rate of tumor growth is related to the
degree of cognitive dysfunction: a fast-growing brain tumor
causes more profound cognitive deficits than a slow-growing
tumour [13, 14]. This is in accordance with the observation
that brain tumor patients show remarkable preservation of
cognitive functioning when compared to patients with acute
lesions of the same size [15]. When comparing the devas-
tating effect of these acute lesions with that of slowly
growing tumors, it is clear that plasticity plays a major role in
the resilience to cognitive deficits in brain tumor patients.
Epilepsy could be considered as one of the manifesta-
tions of brain dysfunction and is often the first manifesta-
tion of a brain tumor. Between 10 and 15% of adult
patients presenting with epileptic seizures are diagnosed
with a brain tumor as the underlying cause of the seizures
[16, 17]. Conversely, most patients suffering from brain
tumors develop epileptic seizures at some point during the
course of their disease. This is the case in 85% of LGG
patients, whereas about 50% of HGG patients will expe-
rience epileptic seizures at some point of their disease [18].
We do not know why some patients develop epileptic
seizures whereas others, suffering from the same tumor
type in the same location, do not.
Specific impact of the different treatment modalities
Surgery, radiotherapy, anti-epileptic drugs, glucocorticoids
and various chemotherapy regimens may have influence on
cerebral functioning of brain tumor patients. But also the
tumor itself, psychological distress, depression and fatigue
have a certain impact, and usually a combination of all
these factors eventually destines how the patient will
function. This makes it difficult to sort out what the con-
tribution of separate treatment modalities may be.
The primary aim of surgery is to reduce tumor mass if
the localization of the tumor allows this. Talacchi and
coworkers (2011) reported a series of 29 glioma patients in
whom extensive neuropsychological examination was
performed both pre- and postoperatively. They found
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postoperative impairment in comparison to preoperative
functioning in 38% of patients and the reverse (postoper-
ative improvement in comparison to preoperative func-
tioning) in 24% of patients [19]. This illustrates that
surgical treatment of brain tumors may be of benefit to
cognitive function, since it reduces intracranial pressure
and compression of brain tissue, but may also cause dam-
age whether transient or more permanent.
Another study in 23 patients harboring a LGG in the
language areas stressed the importance of neuropsycho-
logical assessment before operation: the authors found
transient worsening of verbal working memory immediately
after surgery which recovered within three months [20].
Improvement of language function after initial worsen-
ing following tumor resection was also reported by Sanai
et al. [21].
A lot has been written on the role of radiotherapy on
cerebral functioning. Especially the first reports on cogni-
tive damage in young children who had been treated with
radiotherapy for brain tumors or acute leukemia were
alarming. Later, radiation induced neurotoxicity was also
reported in adults who had been treated with radiotherapy
for primary brain tumors or brain metastases [22, 23].
We performed a study on cognitive functioning among
195 patients with LGG [1]. Our findings suggested that a
mean of 6 years after diagnosis the tumor itself, rather than
the radiotherapy had the most deleterious effect on cognitive
functioning; only high fraction dose radiotherapy ([ 2 Gy)
resulted in significant added cognitive deterioration.
In a follow-up study of the same cohort at a mean of
12 years after first diagnosis, however, it appeared that
long-term survivors of LGG who did not have radiotherapy
had stable cognitive status in contrast to patients who had
received radiotherapy [24]. The latter group showed a
progressive decline in attentional functioning. It is impor-
tant to realize that this attentional deficit developed inde-
pendently of the localization of the tumor and that
treatment in this patient group had been restricted to focal
irradiation. This finding indicates that global cognitive
dysfunctioning may result from local damage.
In patients with HGG, it is more difficult to determine
the long term role of radiotherapy because in these patients
the duration of survival is much shorter than in LGG
patients. Similar to surgical treatment, radiotherapy in
HGG often leads to tumor response and this may result in
improvement of cognitive functioning [25]. A rapid decline
of cognitive functioning occurs in almost all cases of gli-
oma when tumor progression or tumor recurrence occurs.
Glioma patients usually receive various kinds of drugs
during the course of the disease. Epileptic seizures neces-
sitate the prescription of anti-epileptic drugs, and espe-
cially the older or first-generation anti-epileptic drugs
(phenytoin, carbamazepine and valproic acid) may have a
negative influence on cognition. It is interesting and
important to note that levetiracetam, a second generation
drug, may have a positive influence, instead of a deterio-
rating influence on cognition [26].
Cerebral vasogenic edema may accompany glioma
progression and cause neurologic deterioration. Glucocor-
ticoids are usually very effective in the treatment of vas-
ogenic edema, but may also induce new problems with
regard to cognitive and emotional functioning [27].
Nowadays, temozolomide is incorporated in the treat-
ment of most newly diagnosed HGG’s. The use of tem-
ozolomide is not associated with neurocognitive side
effects [28] and may even have a beneficial effect on
seizure frequency [29], but it is very well possible that
other drugs will become part of glioma combined treatment
regimens in the future and some of these drugs may prove
to have neurotoxic side effects.
In conclusion, brain tumors may negatively affect
cerebral functioning and various combinations of all ther-
apeutic modalities, as summarized here, may have an
additional negative, but in some situations also a positive
impact. The study of brain functions and the way these
functions are affected by tumor progression and by various
treatment modalities is usually performed by means of
measurement of function: neurological examination, a
variety of neuropsychological function tests, performance
status scales and quality of life questionnaires are examples
of instruments to—directly or indirectly—assess brain
function. All these functions, however, depend on the
integrity of the cerebral network and direct measurement of
network parameters would have obvious advantages.
Electroencephalography (EEG) and magnetoencephalog-
raphy (MEG) are potential instruments to study these
parameters. If it would become possible to identify certain
characteristics of the human cerebral network, more insight
into the effects of local lesions, such as brain tumors, and
into the effects of systemic treatments on the integrity and
plasticity of the cerebral network could result. We will give
a short overview of network theory and the possibilities to
study neural networks in the following paragraphs.
Network theory and the application in brain research
Network or graph theory originates from both the fields of
mathematics and sociology. Combining these two has led
to a number of methods of analyzing different types of
networks by representing them in an abstract, theoretical
figure called a ‘graph’. The challenge of the study of net-
works—including the study of neural networks—is to find
the optimal method of describing and defining all kinds of
biological and social networks. Networks usually combine
two seemingly opposing concepts: integration and segre-
gation. Most optimal functioning networks have so-called
J Neurooncol (2012) 108:231–237 233
123
‘small-world’ characteristics, referring to a locally clus-
tered architecture in combination with long distance con-
nections. This means that parts of the network that are
virtually remote from each other can actually be linked
through only a few steps. This co-existence of integration
and segregation in complex networks has only recently
been elucidated.
Random networks were first described in the 20th cen-
tury and seemed promising to model complex networks
[30, 31]. However, these graphs did not meet up to the
expectations of explaining the abovementioned small-
world characteristics of networks. Watts and Strogatz
[32] provided an elegant way of modeling small-world
networks. They proposed a very simple model of a one-
dimensional network (see Fig. 1). In the ‘‘regular’’ net-
work, each node or vertex is only connected to its ‘k’
nearest neighbors (k being the degree of the network).
Next, with likelihood ‘p’, connections or edges are chosen
at random and connected to other nodes, also chosen ran-
domly. With increasing p, more and more edges become
randomly reconnected and finally, for p = 1, the network
is completely random. This comprehensible model allows
investigation of all types of networks, ranging from com-
pletely regular to completely random.
The intermediate between random and regular archi-
tecture proved to be crucial to the understanding of the
small-world phenomenon. Two measures appear to be
important for the classification of a network on the con-
tinuum of regular to random. The first measure is the
‘‘clustering coefficient’’ (C), which can be defined as ‘‘the
likelihood that neighbors of a vertex are also connected’’.
The second measure is the so-called ‘‘path length’’ (L).
This is defined as ‘‘the average of the shortest distance
between pairs of nodes counted in the number of edges’’.
Using these two measures, we can resume the theory as
follows: regular networks are very clustered (high C) but it
takes a lot of steps to get from one side of the graph to the
other (high L). In contrast, random networks lack this high
clustering (they have a low C) and the path length is short
(low L). Neither of the two have small-world properties.
However, these small-world properties occur already when
p is only slightly higher than 0: now the path length L drops
sharply, while the clustering coefficient (C) hardly chan-
ges. Thus networks with only a few (randomly) rewired
connections combine both high clustering and a small path
length: this phenomenon is referred to as the small-world
phenomenon. These measures C and L make it possible to
define the index of ‘‘small-worldness’’ [33].
The discovery of these tools to describe small-world
networks initiated a widespread interest in all kinds of
complex networks and gave rise to a wide range of theo-
retical and experimental studies. One of the most intrigu-
ing, and certainly the most complex network is the human
brain. Brain activity is commonly studied by making use of
functional magnetic resonance imaging (fMRI), EEG or
MEG. EEG has been a routine instrument in the study of
brain function for a number of decades. It measures elec-
trical flow and is especially useful for the diagnosis of
epilepsy and other pathological cerebral conditions, such as
encephalitis. MEG is a more sophisticated method to
measure brain activity and has a higher spatial resolution.
MEG registers brain activity by measuring magnetic flow,
and the scalp and the skull do not distort signal registration
in contrast with EEG. Within the signal measured by EEG
and MEG, different frequency bands can be distinguished:
delta (0.5–4 Hz), theta (4–8 Hz), lower alpha (8–10 Hz),
upper alpha (10–13 Hz), beta (13–30 Hz), lower gamma
(30–55 Hz), and upper gamma band (55–80 Hz).
A fundamental conception for the study of brain
dynamics is ‘‘synchronization’’ or ‘‘functional connectiv-
ity’’. The basic assumption of functional connectivity is
that statistical interdependencies between time series of
brain activity at separate areas reflect functional interac-
tions between these brain regions [34]. This functional
connectivity can be calculated on the basis of the amount
of synchrony of brain activity measured in two different
areas. The conception is that multiple local networks
are maintained by long-distance patterns of functional
connectivity and this results in higher and complex brain
functions, such as planning, memory, and executive func-
tioning [35–38]. Functional connectivity between brain
areas may thus be used to construct graphs of the brain (see
Fig. 2 for an example in an MEG recording). The two
prerequisites of local segregation, referring to local spe-
cialization in specific tasks, and integration, combining
information from lower-level networks at a higher and
more global level, are thought to be crucial for optimal
brain functioning [39–41]. The small-world network is a
highly adequate model of organization in the brain,
Fig. 1 Schematic drawing of a random, a regular, and a small-world
network. In the regular network (left), each node is only connected to its
neighbors. Therefore, it has both a high clustering coefficient (C) and a
long path length (L), while the random network (right) combines a low
C and a low L. The intermediate of the two: the so-called ‘‘small-world
network’’ (middle) can be achieved by relocating but a few long-
distance connections from the regular network, which causes L to
decrease drastically but preserves a high C. Thus it combines ‘‘the best
of two worlds’’
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because it supports both segregated as well as integrated
information processing [42]. Brain tumors may interfere
with neuronal structures and the resulting disturbances of
anatomical connectivity may lead to alterations of func-
tional connectivity patterns [43, 44].
Functional connectivity and neural networks
in the presence of a brain tumor: the impact
on cognition and the impact on epilepsy
During the last decade, we have shown that most LGG
and HGG patients perform significantly worse than heal-
thy controls on almost all cognitive tests. In order to
better understand why glioma patients develop those
global cognitive deficits, we investigated the correlation
between resting-state MEG-based functional connectivity
and cognitive functioning in patients with LGG [45]. We
therefore studied correlations between time series of 126
MEG channels and we used the so-called ‘‘synchroniza-
tion likelihood’’ (SL) as one of the measures of syn-
chronization (or functional connectivity). The SL varies
between zero (no synchronization at all) and one (total
synchronization).
We found that LGG patients showed increased SL in the
delta, theta, and lower gamma frequency bands in com-
parison to healthy controls, while connectivity in the lower
alpha band was decreased. In another study we also found a
correlation between cognitive functioning and network
architecture in LGG patients [46].
These findings partly confirmed our previous studies, in
which we also found changes in functional connectivity
and network architecture in brain tumor patients with
various histologies [47, 48]. There were some contradictory
details between the earlier publications and the results of
the later papers, especially regarding differences between
tumor patients and healthy controls in the pattern and the
direction of changes in connectivity in the various fre-
quency bands. Possible explanations for these differences
in both functional connectivity and network topology may
relate to the different patient samples: a homogeneous
group of LGG patients versus a more heterogeneous sam-
ple of brain tumor patients.
Despite these contradictory details, it is most likely that
conceptions like functional connectivity and network
topology are pivotal for cognitive functioning. Both cog-
nitive performance and functional connectivity are dis-
turbed in LGG patients, and correlations exist between
these two phenomena. Brain tumor patients consistently
show pathologically increased connectivity particularly in
the lower frequency bands (delta, theta), which is related to
poorer cognitive functioning.
We further investigated network characteristics in gli-
oma patients with epilepsy by means of MEG registrations
[49]. Functional connectivity was calculated in six fre-
quency bands, as were a number of network measures such
as normalized clustering coefficient and path length.
Increased theta band connectivity appeared to be related to
a higher total number of seizures. Furthermore, higher
Fig. 2 Part of a 151-channel
MEG recording.
Synchronization of signals from
different regions of the brain is a
measure of connectivity of these
regions
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number of seizures was related to a less optimal, more
random brain network topology. Other factors were not
significantly related to functional connectivity or network
topology. These results indicate that (pathologically)
increased theta band connectivity is related to a higher
number of epileptic seizures in brain tumor patients, sug-
gesting that theta band connectivity changes are a hallmark
of tumor-related epilepsy. Furthermore, a more random
brain network topology is related to greater vulnerability to
seizures. Thus, functional connectivity and brain network
architecture may prove to be important parameters of
tumor-related epilepsy.
Concluding remarks
Brain tumors and brain tumor treatment lead to disturbances
in cerebral function. These disturbances may consist of
function loss (especially loss of complex functions), and
epileptic seizures. It has been shown that both types of
cerebral function disruption are associated with changes in
functional connectivity and network architecture. Although
we are only in the very beginning of unraveling the extre-
mely complex network architecture of the brain, the findings
in brain tumor patients may prove to be of great importance
for our future strategies in the treatment of these patients.
Possibilities to successfully combine brain tumor surgery
and epilepsy surgery will improve, and we will be able to
longitudinally study the influence of various treatment
strategies on the network. In short, we will be able to study
the plasticity of the brain in a direct and non-invasive way.
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